Cue Biopharma任命Shao-Lee Lin博士为首席执行官、总裁兼董事会董事,引领公司持续增长并向临床阶段转型

美股速递
May 01

Cue Biopharma, Inc.正式宣布,任命Shao-Lee Lin博士(医学博士、哲学博士)担任公司首席执行官、总裁以及董事会董事。此项重要人事任命旨在推动公司实现持续的业务增长,并顺利完成向临床阶段生物制药企业的战略转型。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10